Promacta 50 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FGPXH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,027
Award facts
- Contract value 100% obligated
- $8,026.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Promacta 50 mg tablets (30-count units), with an ultimate completion date of October 17, 2025. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across the Department of Defense and military healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Promacta—an immunosuppressant medication used to treat thrombocytopenia—exemplifies the company's role in fulfilling critical medical supply needs for Department of Defense and Defense Health Agency customers. AmerisourceBergen's consistent receipt of competitively awarded delivery orders with firm fixed pricing across varying transaction sizes demonstrates the company's capability to meet federal medical procurement requirements and support military readiness through reliable pharmaceutical supply chain management.
Quick answers
Who was awarded contract SPE2DB25FGPXH?
SPE2DB25FGPXH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FGPXH worth?
The government has obligated $8,027 on SPE2DB25FGPXH.
Is contract SPE2DB25FGPXH an order under another contract?
Yes. SPE2DB25FGPXH is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPXH competed?
The extent of competition for SPE2DB25FGPXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award